Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Scott Lucia

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6Gretchen E Garcia, Hans-Georg Wisniewski, M Scott Lucia, et al.
Urology|February 19, 2008
Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancerKenneth A Iczkowski, Deloar Hossain, Kathleen C Torkko, et al.
Translational Oncology|May 5, 2009
Loss of NADPH quinone oxidoreductase in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant 2alpha in hormone-stimulated noble rats: potential role in prostatic intraepithelial neoplasia developmentRita Ghosh, John Schoolfield, I-Tien Yeh, et al.
Urology|August 5, 2011
Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinomaThomas W Flaig, Shandra Wilson, Adrie van Bokhoven, et al.
Molecular Cancer Research : MCR|January 7, 2022
MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress SignalingMadison Furnish, Dillon P Boulton, Victoria Genther, et al.
JAMA Oncology|July 17, 2015
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Wendy E Barrington, Jeannette M Schenk, Ruth Etzioni, et al.
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patientsClaire L Ihle, Meredith D Provera, Desiree M Straign, et al.
European Urology Focus|March 21, 2026
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein ModelEmily A Vertosick, Phyllis Goodman, Catherine M Tangen, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6Gretchen E Garcia, Hans-Georg Wisniewski, M Scott Lucia, et al.
Urology|February 19, 2008
Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancerKenneth A Iczkowski, Deloar Hossain, Kathleen C Torkko, et al.
Translational Oncology|May 5, 2009
Loss of NADPH quinone oxidoreductase in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant 2alpha in hormone-stimulated noble rats: potential role in prostatic intraepithelial neoplasia developmentRita Ghosh, John Schoolfield, I-Tien Yeh, et al.
Urology|August 5, 2011
Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinomaThomas W Flaig, Shandra Wilson, Adrie van Bokhoven, et al.
Molecular Cancer Research : MCR|January 7, 2022
MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress SignalingMadison Furnish, Dillon P Boulton, Victoria Genther, et al.
JAMA Oncology|July 17, 2015
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Wendy E Barrington, Jeannette M Schenk, Ruth Etzioni, et al.
JAMA|July 7, 2005
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lowerIan M Thompson, Donna Pauler Ankerst, Chen Chi, et al.
Current Medical Research and Opinion|December 11, 2013
Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancerNeal Shore, Raoul Concepcion, Daniel Saltzstein, et al.
Journal for Immunotherapy of Cancer|November 10, 2019
Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patientsClaire L Ihle, Meredith D Provera, Desiree M Straign, et al.
European Urology Focus|March 21, 2026
Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein ModelEmily A Vertosick, Phyllis Goodman, Catherine M Tangen, et al.
Pageof 17